Boiron Inc.

FDA Regulatory Profile

Boiron Inc. appears in FDA public data with 1 recall, 0 510(k) clearances, 14 FDA inspections, and 1 compliance action on record. Its most recent recall (D-0803-2018, Class III) was initiated on April 13, 2018.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
14
Compliance Actions
1

Recent Recalls

NumberClassProductDate
D-0803-2018Class IIICalendula Cream, calendula officinalis 1X HUS-10%, 2.5 oz. tubes, Distributed by Boiron Inc., NewtowApril 13, 2018